I just started researching a new genomics test from Artera ( artera.ai/our-science/ ).
Supposed to do a better job at risk stratification for high risk/very high risk prostate cancer patients. This could lead to more personalized treatments for these patients. Does any one have first hand knowledge of the test? Did it influence your treatment decisions?
Also see: urologytimes.com/view/dr-sp...
Advise on Genetic Testing & Genomic Testing 
Genetic testing found several genomic alterations
SBRT for low/intermediate risk prostate cancer has excellent 5-year outcomes
Treatment of High Risk Advanced and M1 Disease: Is There a Role for Treatment of the Primary?
Increased risk of dementia with ADT, especially Degarelix?
